MRCK β Antibodies

Santa Cruz Biotechnology provides a broad selection of MRCK β monoclonal antibodies for advanced research in cellular signaling and regulation. MRCK β monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MRCK β, or myotonic dystrophy kinase-related Cdc42-binding kinase β, plays a crucial role in cytoskeletal dynamics and cell motility, influencing processes such as cell migration and invasion. MRCK β functions in various signaling pathways, making it an important target for understanding cancer progression and other diseases. Studying MRCK β expression and activity patterns helps reveal molecular mechanisms underlying key biological processes. Researchers worldwide rely on MRCK β monoclonal antibodies to advance their investigations in cell biology and disease mechanisms. MRCK β monoclonal antibodies enable precise detection and analysis of protein localization, interactions, and modifications. Santa Cruz Biotechnology monoclonal antibodies for MRCK β support researchers in making meaningful contributions to scientific understanding of cellular regulation and disease progression.